Cell Therapeutics Continues Climbing

Shares of Cell Therapeutics Inc. (NYSE: CTIC) continued to rise by gaining 15 cents to close at $1.46 after announcing that the Eurpean Medicines Agency's Committee for Medicinal Products for Human Use may issue an opinion of the company's Marketing Authorization Application for Pixuvri in mid-February.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here